- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06930534
Portable Rapid Imaging for Medical Emergencies (PRIME)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The primary objective of this study is to determine whether portable brain MRI reduces the time from scan order to scan start in the emergency department as compared to conventional brain MRI. The secondary objectives of this study are 1) to measure the percentage of scans that are completed after order and the time from order to completion, 2) to compare findings on portable MRI to conventional brain imaging findings, 3) to compare the total length of stay between the portable MRI and conventional MRI groups, and 4) to understand the impact of portable MRI scans on decision making and provider satisfaction based on qualitative surveys administered to a physician endpoint panel. This is a prospective, observational, randomized study. Participants will be recruited from the pool of patients ordered for a brain MRI, with or without contrast and excluding hyperacute MRI, in the emergency department. Participants will be randomized to one of two treatment groups, scan or standard-of-care (SOC). Participants in the scan arm will receive a portable MRI scan as soon as the scanner is available after randomization.
Participants in the SOC arm will not receive a portable MRI scan as part of their initial evaluation. Regardless of randomization arm, all participants will receive their scheduled conventional MRI as usual. Information on each participant's clinical course, conventional imaging, and length of stay will be collected, regardless of treatment group. On a rolling basis, surveys containing deidentified clinical information and portable MRI scans will be administered to a physician panel to assess the impact of portable MRI scans on decision making and provider satisfaction.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06520
- Yale New Haven Health Emergency Department
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male or female ≥ 18 years of age at presentation to Yale New Haven Hospital Adult ED
- Order to receive conventional brain MRI imaging originating in the YNHH Adult ED
Exclusion Criteria:
- Lack of assent from treating physician for inclusion in this protocol.
Contraindications to 1.5T MRI evaluation, including:
- Cardiac Pacemaker or defibrillator
- Aneurysm clip
Implants or devices attached to the body in the chest or above, such as:
- Nerve stimulator
- Deep brain stimulator
- Programmable shunt
- Stent
- Pain pump
- Artificial extremity
- Implants in the ears (hearing aid or cochlear implant
- Any shrapnel, pellets, bullets, metallic fragments, or other metallic foreign body above the chest
- Metallic joints, rods, screws, or other orthopedic implants in or above the chest
- Braces, dentures, removable teeth, or dental expanders that cannot be removed.
- Body piercings in or above the chest that cannot be removed.
- MRI-incompatible Tracheostomy tube or Swan Ganz catheter in place
- Status Epilepticus or anyone previously seizing deemed by the physician not to be suitable for pMRI
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Portable Brain MRI scan
Participants in the scan arm will receive a portable MRI scan as soon as the scanner is available after randomization as part of their initial evaluation.
Regardless of randomization arm, all participants will receive their scheduled conventional MRI as usual.
|
portable brain MRI scanner
|
|
No Intervention: Standard of Care
Participants in the SOC arm will not receive a portable MRI scan as part of their initial evaluation.
Regardless of randomization arm, all participants will receive their scheduled conventional MRI as usual.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to start of scan
Time Frame: immediately post MRI (Day 1)
|
The primary outcome is time from MRI order to assigned arm scan initiation, analyzed as cumulative initiation at the prespecified time points of 3,6,9, and 12 hours.
|
immediately post MRI (Day 1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Portable MRI Findings
Time Frame: immediately post MRI (Day 1)
|
The frequency of acute findings (e.g., ischemic stroke, intracranial hemorrhage) using the portable MRI will be compared between groups.
|
immediately post MRI (Day 1)
|
|
Length of Stay
Time Frame: immediately post MRI (Day 1)
|
Total Emergency Department length of stay
|
immediately post MRI (Day 1)
|
|
Non-Completed Scans
Time Frame: immediately post missed MRI (Day 1)
|
To document the reasons for non-completion of MRI scans
|
immediately post missed MRI (Day 1)
|
|
Time to scan during hospital encounter
Time Frame: immediately post MRI (Day 1)
|
Time in hours from MRI order to scan initiation among participants whose assigned examination was initiated during the same hospital encounter.
|
immediately post MRI (Day 1)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Adam de Havenon, MD, Yale University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2000039013
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patient Satisfaction
-
Shaukat Khanum Memorial Cancer Hospital & Research...CompletedSatisfaction, Patient | SatisfactionPakistan
-
Duke UniversityCompletedPatient Satisfaction | Clinician SatisfactionUnited States
-
Universitair Ziekenhuis BrusselWithdrawnPatient Satisfaction | Patient PreferenceBelgium
-
Cedars-Sinai Medical CenterTerminated
-
HaEmek Medical Center, IsraelUnknownPatient Satisfaction | Patient Compliance
-
Acibadem UniversityCompletedPatient Satisfaction | Patient Relations, NurseTurkey
-
Methodist Health SystemCompletedSatisfaction, PatientUnited States
-
University Hospital, ToulouseCompletedSatisfaction, PatientFrance
-
University of AarhusAarhus University HospitalCompletedPatient Satisfaction | Patient-Centered CareDenmark
-
Dr Abdurrahman Yurtaslan Ankara Oncology Training...CompletedPatient Satisfaction | Bowel Preparation | Patient ExperienceTurkey
Clinical Trials on Swoop Plus Mk2.0
-
Qure Healthcare, LLCLineagenCompletedIntellectual Disability | Developmental DelayUnited States
-
University of South CarolinaNational Cancer Institute (NCI); American Cancer Society, Inc.CompletedBreast CancerUnited States
-
Texas A&M UniversityUniversity of Arkansas; Arkansas Children's Hospital Research InstituteCompletedCystic FibrosisUnited States
-
The University of Tennessee, KnoxvilleNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Cherokee...CompletedObesity | Childhood ObesityUnited States
-
ResMedCompletedSleep Apnea, Obstructive | Sleep Apnea, CentralGermany
-
Alma Lasers Inc.Unknown
-
BioVersys AGNot yet recruitingTuberculosis Meningitis
-
Ethicon, Inc.Completed
-
Farmaceutici Damor SpaRecruitingWounds and Injuries | Wound Infection | Wound HealItaly
-
University of TrierGerman Research FoundationCompletedFeedback, PsychologicalGermany